Importance of the Re-Transurethral Resection in Bladder Cancer Treatment
Journal Title: Üroonkoloji Bülteni - Year 2016, Vol 15, Issue 3
Abstract
Objective: In this study, we aimed to investigate the importance of repeat-transurethral resection (re-TUR) in bladder cancer treatment. Materials and Methods: A total of 90 with the diagnosis of grade pTa and all pT1 bladder cancer were included in the study. Re-TUR was performed in all patients 2-6 weeks after the initial TUR. Results: Six patients (6.6%) were re-staged as T2 according to the histopathological analysis of re-TUR specimens. The incidence of residual tumor following re-TUR performed by experienced surgeons was not statistically significant (p>0.05). Conclusion: Re-TUR allows more accurate staging and effective treatment for patients with T1 high-grade bladder cancer in whom radical cystectomy can be a more effective treatment option.
Authors and Affiliations
Fehmi Narter, Fatih Tarhan, Erkin Sağlam, Kutluhan Erdem, Övünç Kavukoğlu, Emre Çamur, Gökhan Faydacı
Keywords
Related Articles
- EP ID EP228291
- DOI 10.4274/uob.703
- Views 119
- Downloads 0
Incidental Amyloidosis of the Seminal Vesicle: A Case Report and Review of the Literature
With a widely usage of prostate specific antigen (PSA) testing as a screening tool, number of prostate biopsy procedures and number of biopsy cores are increased because of the negative pathology results. As a result of...
Is Prostate Cancer Related to Low Vitamin D Level?
Objective: Prostate cancer (PC) is the most common malignancy among men worldwide. There are several epidemiological studies linking the risk and outcome of vitamin D with PC. In this study, we aimed to compare vitamin D...
What is the Color of Cancer?
Objective: To investigate the colors that evokes cancer in the patients with prostate, lung and breast cancer, and in healthy controls. Materials and Methods: A visual card in one of the 9 colors (white, red, orange, ye...
Evaluation of the Side Effect Profile of Intracavitary Bacillus Calmette-Guérin Treatment in Non-muscle-invasive Bladder Cancer
Objective: To reveal the association of side effect profiles seen in patients receiving intravesical bacillus Calmette-Guérin (BCG) immunotherapy for non-muscle-invasive bladder cancer (NMIBC) treatment with patient age...
Current Status in the Surgery and Conservative Management of Upper Urinary System Tumors
Upper urinary tract urothelial cancers constitute 5% of all urothelial cancers and standard therapy is bladder cuff excision with nephroureterectomy. This treatment is performed as open or technologically assisted (lapar...